---
title: "Altretamine - Malignant tumor of ovary - 2"
sidebar: mydoc_sidebar
permalink: db00488-mesh-d010051-2.html
toc: false 
---


Path ID: `DB00488_MESH_D010051_2`
{% include image.html url="images/db00488-mesh-d010051-2.png" file="db00488-mesh-d010051-2.png" alt="db00488-mesh-d010051-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D006585 | altretamine | Drug |
| InterPro:IPR001128 | CYP450 enzymes | GeneFamily |
| CHEBI:73080 | carbinolamine | ChemicalSubstance |
| GO:0070989 | N-demethylation | MolecularActivity |
| CL:0001063 | tumor cells | Cell |
| MESH:D010051 | Malignant tumor of ovary | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Altretamine | INCREASES ACTIVITY OF | Cyp450 Enzymes |
| Cyp450 Enzymes | PRODUCES | Carbinolamine |
| Carbinolamine | ENABLED BY | N-Demethylation |
| N-Demethylation | DISRUPTS | Tumor Cells |
| Tumor Cells | CAUSES | Malignant Tumor Of Ovary |
|---------|-----------|---------|

Reference: 
  - [https://en.wikipedia.org/wiki/Altretamine#Mechanism](https://en.wikipedia.org/wiki/Altretamine#Mechanism)
